Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O15400

Entry ID Method Resolution Chain Position Source
AF-O15400-F1 Predicted AlphaFoldDB

190 variants for O15400

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1562340319
CA365687632
2 S>C No ClinGen
Ensembl
rs1479392994
CA365687630
3 Y>N No ClinGen
TOPMed
CA365687622
rs752794991
4 T>A No ClinGen
ExAC
gnomAD
rs752794991
CA4003860
4 T>S No ClinGen
ExAC
gnomAD
rs1310681876
CA365687612
5 P>L No ClinGen
TOPMed
gnomAD
rs1354594719
CA365687615
5 P>S No ClinGen
gnomAD
CA4003858
rs760092171
6 G>E No ClinGen
ExAC
gnomAD
rs369562473
CA4003857
11 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA365687577
rs369562473
11 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4003854
rs1044057
12 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA365687569
rs1562340254
13 Q>E No ClinGen
Ensembl
rs760207182
CA4003852
13 Q>H No ClinGen
ExAC
gnomAD
rs1186044216
CA365687551
15 A>D No ClinGen
gnomAD
CA4003850
rs771903230
18 I>M No ClinGen
ExAC
gnomAD
CA4003849
rs745880493
19 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs1364281387
CA365687521
20 S>C No ClinGen
TOPMed
CA4003848
rs773991133
21 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA4003847
rs770796111
22 I>V No ClinGen
ExAC
gnomAD
CA4003846
rs372605930
26 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4003845
rs777920429
27 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs756340040
CA4003843
28 C>Y No ClinGen
ExAC
CA147979425
rs938409398
32 I>M No ClinGen
Ensembl
rs755045655
CA4003820
32 I>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
CA4003819
COSM277518
rs747083359
34 R>I Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA365687397
rs1187133503
37 N>S No ClinGen
gnomAD
rs201355710
CA147979416
38 Q>* No ClinGen
1000Genomes
CA365687390
rs1453899868
38 Q>L No ClinGen
TOPMed
gnomAD
CA365687391
rs1453899868
38 Q>R No ClinGen
TOPMed
gnomAD
rs758981256
CA4003817
39 L>R No ClinGen
ExAC
TOPMed
gnomAD
rs1459272607
CA365687385
39 L>V No ClinGen
gnomAD
rs755811211
CA147979394
44 D>A No ClinGen
ExAC
TOPMed
gnomAD
rs755811211
CA4003814
44 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA365687336
rs1201981928
47 E>* No ClinGen
gnomAD
CA278780
rs864309676
RCV000203258
53 Q>H No ClinGen
ClinVar
Ensembl
dbSNP
rs761610600
CA147977345
57 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs761610600
CA4003786
57 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA147977337
rs978366367
59 T>A No ClinGen
Ensembl
CA365687220
rs1484513282
61 Q>* No ClinGen
gnomAD
CA4003782
rs775613410
64 K>R No ClinGen
ExAC
gnomAD
CA4003781
rs772313425
65 E>Q No ClinGen
ExAC
gnomAD
CA365687175
rs1582653772
67 D>E No ClinGen
Ensembl
CA365687172
rs1222194923
68 K>* No ClinGen
TOPMed
gnomAD
CA147977307
rs113421354
72 E>G No ClinGen
Ensembl
CA4003779
rs779517620
73 F>I No ClinGen
ExAC
TOPMed
gnomAD
rs1237596474
CA365687125
COSM164678
74 G>E breast [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 75 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 76 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs778068381
CA4003776
77 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs778068381
CA365687108
77 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs754646108
CA4003774
78 T>I No ClinGen
ExAC
CA147977254
rs772408320
79 T>I No ClinGen
Ensembl
rs4410755
CA147977259
79 T>P No ClinGen
Ensembl
CA4003772
rs779508895
80 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA4003771
rs757854094
81 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA365687078
rs1384422744
83 Q>K No ClinGen
gnomAD
rs758050027
CA4003750
84 R>C No ClinGen
ExAC
gnomAD
rs745375542
CA4003749
84 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs758050027
CA4003751
84 R>S No ClinGen
ExAC
gnomAD
TCGA novel 86 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs778450295
CA4003748
88 I>M No ClinGen
ExAC
gnomAD
rs1161993252
CA365687004
91 D>V No ClinGen
gnomAD
COSM2153252
rs773741919
CA4003747
92 R>C Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA365686999
rs1365783081
92 R>H No ClinGen
gnomAD
rs903617367
CA147976781
96 E>K No ClinGen
Ensembl
CA365686955
rs1459624839
99 T>A No ClinGen
TOPMed
gnomAD
CA147976779
rs202107481
100 S>L No ClinGen
1000Genomes
rs1383897323
CA365686935
102 T>I No ClinGen
TOPMed
rs200115851
CA4003745
103 N>D No ClinGen
ExAC
gnomAD
rs1461206436
CA365686920
104 F>L No ClinGen
gnomAD
CA4003743
rs752556609
107 V>A No ClinGen
ExAC
gnomAD
rs755820982
CA4003744
107 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA4003742
rs767785107
110 Q>* No ClinGen
ExAC
TOPMed
gnomAD
rs767785107
CA365686883
110 Q>K No ClinGen
ExAC
TOPMed
gnomAD
rs770542402
CA147976743
111 A>P No ClinGen
Ensembl
CA365686873
rs1562324571
111 A>V No ClinGen
Ensembl
rs946492195
CA147976742
112 A>V No ClinGen
TOPMed
rs1193625974
CA365686867
113 E>K No ClinGen
gnomAD
CA4003739
rs763486294
114 R>* No ClinGen
ExAC
TOPMed
gnomAD
CA4003738
rs763486294
114 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA4003737
rs773552054
114 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA365686856
rs1240326596
115 E>Q No ClinGen
TOPMed
CA4003735
rs770348151
118 F>L No ClinGen
ExAC
gnomAD
CA4003734
rs748444335
119 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA4003733
rs777045654
121 R>* No ClinGen
ExAC
gnomAD
rs1042027145
CA147976701
121 R>L No ClinGen
TOPMed
rs1042027145
CA365686813
121 R>Q No ClinGen
TOPMed
TCGA novel 122 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365686799
rs1302570377
124 A>T No ClinGen
gnomAD
CA4003732
rs771698278
125 S>G No ClinGen
ExAC
gnomAD
CA365686773
rs1372867837
128 V>M No ClinGen
gnomAD
CA147976061
rs778849596
136 S>G No ClinGen
TOPMed
rs1030879925
CA147976050
137 S>* No ClinGen
TOPMed
CA365686691
rs1273748303
138 K>Q No ClinGen
TOPMed
CA365686669
rs1374301510
141 N>H No ClinGen
gnomAD
rs1218785494
CA365686666
141 N>S No ClinGen
gnomAD
CA365686656
rs1436076870
143 V>I No ClinGen
gnomAD
rs776955652
CA4003714
145 W>* No ClinGen
ExAC
gnomAD
CA365686634
rs1173683694
146 E>* No ClinGen
gnomAD
rs1307445408
CA365686627
147 S>G No ClinGen
TOPMed
rs201529204
CA4003696
149 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs201529204
CA4003697
149 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs369931134
CA4003694
151 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4003693
rs142460328
153 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs775932086
CA4003692
154 Q>L No ClinGen
ExAC
TOPMed
gnomAD
CA365686567
rs775932086
154 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA147975539
rs540939045
155 V>M No ClinGen
1000Genomes
TOPMed
gnomAD
CA4003691
rs147685020
157 D>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs772576698
CA4003690
158 E>D No ClinGen
ExAC
gnomAD
rs1270865726
CA365686516
161 T>I No ClinGen
gnomAD
CA4003686
rs747692662
163 D>H No ClinGen
ExAC
gnomAD
CA4003685
rs781228048
165 L>F No ClinGen
ExAC
gnomAD
CA4003684
rs768719136
166 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs746775126
CA4003683
166 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA365686486
rs768719136
166 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA365686473
rs1379593472
168 I>T No ClinGen
gnomAD
CA4003681
rs758525798
170 E>G No ClinGen
ExAC
gnomAD
CA365686377
rs148495140
COSM1073381
180 A>D Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4003661
rs148495140
180 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs777889796
CA4003659
COSM1073380
181 D>G Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4003660
rs749370601
181 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs756560065
CA4003658
182 I>T No ClinGen
ExAC
gnomAD
rs867860684
CA147974603
184 D>N No ClinGen
Ensembl
rs1232962590
CA365686344
185 I>T No ClinGen
gnomAD
rs1347746765
CA365686324
188 I>L No ClinGen
gnomAD
rs144864017
CA4003657
191 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA365686300
rs1299829879
191 D>Y No ClinGen
gnomAD
rs149848428
CA4003656
193 G>R No ClinGen
ESP
ExAC
gnomAD
CA4003654
rs751884427
194 M>I No ClinGen
ExAC
gnomAD
rs1459709466
CA365686261
196 I>M No ClinGen
TOPMed
rs764975922
CA4003653
196 I>T No ClinGen
ExAC
gnomAD
CA4003651
rs201892382
200 G>R No ClinGen
ExAC
gnomAD
CA4003650
rs763736446
201 D>N No ClinGen
ExAC
gnomAD
rs760131896
CA4003649
202 V>G No ClinGen
ExAC
gnomAD
rs1407030823
CA365686213
203 I>M No ClinGen
gnomAD
CA365686216
rs1433554186
203 I>T No ClinGen
gnomAD
rs1251514865
CA365686195
204 D>G No ClinGen
TOPMed
rs774112518
CA4003625
205 S>I No ClinGen
ExAC
gnomAD
rs770756173
CA4003624
206 I>K No ClinGen
ExAC
rs1582646331
CA365686178
207 E>K No ClinGen
Ensembl
rs1396711703
CA365686166
208 A>G No ClinGen
gnomAD
CA365686169
rs1314883777
208 A>T No ClinGen
gnomAD
rs762768849
CA4003623
209 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs773375272
CA4003622
210 V>M No ClinGen
ExAC
gnomAD
CA4003621
rs769921819
211 E>Q No ClinGen
ExAC
gnomAD
COSM1698008
rs748192631
CA4003620
212 N>K skin [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA365686133
rs1179604332
213 A>G No ClinGen
TOPMed
CA365686138
rs1163718645
213 A>T No ClinGen
gnomAD
CA4003619
rs530542469
214 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs530542469
CA365686132
214 E>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs1164816730
CA365686115
216 H>R No ClinGen
gnomAD
CA4003616
rs780736873
217 V>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 220 A>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA365686086
rs1249089671
220 A>G No ClinGen
gnomAD
CA365686090
rs1372443650
220 A>T No ClinGen
gnomAD
rs1209640875
CA365686080
221 N>S No ClinGen
TOPMed
gnomAD
rs1209640875
CA365686081
221 N>T No ClinGen
TOPMed
gnomAD
rs970685870
CA147995765
222 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs750828676
CA4003614
223 Q>R No ClinGen
ExAC
gnomAD
COSM3777123
CA365686048
COSM3777124
rs777413406
226 R>K Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4003613
rs777413406
226 R>T No ClinGen
ExAC
gnomAD
CA4003612
rs755786190
228 A>V No ClinGen
ExAC
gnomAD
CA4003577
rs773669589
232 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4003576
rs746429926
232 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA4003575
rs376336706
234 S>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA365685890
rs1368781628
237 T>N No ClinGen
gnomAD
TCGA novel 237 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1582643008
CA365685884
238 L>P No ClinGen
Ensembl
rs1269626265
CA365685878
239 C>Y No ClinGen
gnomAD
CA365685873
rs1228675641
240 I>V No ClinGen
gnomAD
CA4003573
rs372354234
241 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1390827242
CA365685843
244 I>M No ClinGen
TOPMed
CA365685844
rs964239635
244 I>S No ClinGen
TOPMed
CA147993900
rs964239635
244 I>T No ClinGen
TOPMed
rs1385676566
CA365685840
245 L>F No ClinGen
TOPMed
rs1385676566
CA365685842
245 L>I No ClinGen
TOPMed
CA147993894
rs1017026752
247 I>T No ClinGen
TOPMed
gnomAD
rs774205615
CA147993899
247 I>V No ClinGen
Ensembl
CA4003572
rs780651725
248 G>E No ClinGen
ExAC
gnomAD
CA365685818
rs1342713051
249 V>I No ClinGen
gnomAD
CA365685810
rs1335463098
250 A>G No ClinGen
TOPMed
gnomAD
CA365685809
rs1335463098
250 A>V No ClinGen
TOPMed
gnomAD
rs746519125
CA4003570
251 I>M No ClinGen
ExAC
gnomAD
rs368749896
CA4003571
251 I>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4003569
rs779598894
254 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA365685787
rs779598894
254 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1006072855
CA147993866
256 I>V No ClinGen
TOPMed
gnomAD
CA4003567
rs375044570
258 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1355809552
CA365685757
258 G>V No ClinGen
TOPMed
CA365685743
rs1187925289
260 N>K No ClinGen
gnomAD
CA365685741
rs1463356594
261 H>N No ClinGen
gnomAD

No associated diseases with O15400

3 regional properties for O15400

Type Name Position InterPro Accession
domain Target SNARE coiled-coil homology domain 160 - 252 IPR000727
domain Syntaxin, N-terminal domain 3 - 148 IPR006011
conserved_site Syntaxin/epimorphin, conserved site 171 - 210 IPR006012

Functions

Description
EC Number
Subcellular Localization
  • Early endosome membrane ; Single-pass type IV membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

19 GO annotations of cellular component

Name Definition
azurophil granule Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
early endosome A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
early endosome membrane The lipid bilayer surrounding an early endosome.
endocytic vesicle A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
endomembrane system A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
endosome A vacuole to which materials ingested by endocytosis are delivered.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
immunological synapse An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
late endosome A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
lysosomal membrane The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
lysosome A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
recycling endosome An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
SNARE complex A protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. One well-characterized example is the neuronal SNARE complex formed of synaptobrevin 2, syntaxin 1a, and SNAP-25.
synaptic vesicle A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
tertiary granule A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells.
vesicle Any small, fluid-filled, spherical organelle enclosed by membrane.

4 GO annotations of molecular function

Name Definition
chloride channel inhibitor activity Binds to and stops, prevents, or reduces the activity of a chloride channel.
SNAP receptor activity Acting as a marker to identify a membrane and interacting selectively with one or more SNAREs on another membrane to mediate membrane fusion.
SNARE binding Binding to a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein.
syntaxin binding Binding to a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse.

8 GO annotations of biological process

Name Definition
intracellular protein transport The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell.
organelle assembly The aggregation, arrangement and bonding together of a set of components to form an organelle. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
organelle localization Any process in which an organelle is transported to, and/or maintained in, a specific location.
positive regulation of receptor localization to synapse Any process that activates or increases the frequency, rate or extent of receptor localization to synapse.
positive regulation of T cell mediated cytotoxicity Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
regulation of protein localization to plasma membrane Any process that modulates the frequency, rate or extent of protein localization to plasma membrane.
vesicle docking The initial attachment of a transport vesicle membrane to the target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane. Docking requires only that the two membranes come close enough for these proteins to interact and adhere.
vesicle fusion Fusion of the membrane of a transport vesicle with its target membrane.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32854 PEP12 Syntaxin PEP12 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q3ZBT5 STX7 Syntaxin-7 Bos taurus (Bovine) PR
Q7KVY7 Syx4 Syntaxin-4 Drosophila melanogaster (Fruit fly) PR
Q12846 STX4 Syntaxin-4 Homo sapiens (Human) PR
P61266 STX1B Syntaxin-1B Homo sapiens (Human) PR
O75558 STX11 Syntaxin-11 Homo sapiens (Human) PR
Q16623 STX1A Syntaxin-1A Homo sapiens (Human) PR
O70439 Stx7 Syntaxin-7 Mus musculus (Mouse) PR
O70257 Stx7 Syntaxin-7 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MSYTPGVGGD PAQLAQRISS NIQKITQCSV EIQRTLNQLG TPQDSPELRQ QLQQKQQYTN
70 80 90 100 110 120
QLAKETDKYI KEFGSLPTTP SEQRQRKIQK DRLVAEFTTS LTNFQKVQRQ AAEREKEFVA
130 140 150 160 170 180
RVRASSRVSG SFPEDSSKER NLVSWESQTQ PQVQVQDEEI TEDDLRLIHE RESSIRQLEA
190 200 210 220 230 240
DIMDINEIFK DLGMMIHEQG DVIDSIEANV ENAEVHVQQA NQQLSRAADY QRKSRKTLCI
250 260
IILILVIGVA IISLIIWGLN H